BNC Wealth Management LLC Invests $2.10 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

BNC Wealth Management LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,554 shares of the biopharmaceutical company’s stock, valued at approximately $2,099,000. A number of other institutional investors […]

Related Keywords

Michaels Brown ,Arthurf Ryan ,Raymond James ,Steward Financial Group ,Bnc Wealth Management ,Quarter For Regeneron Pharmaceuticals ,Jpmorgan Chase Co ,Insider Activity At Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals ,Trifecta Capital Advisors ,Nasdaq ,Regeneron Pharmaceuticals Profile ,Regeneron Pharmaceuticals Inc ,Barclays ,News Ratings For Regeneron Pharmaceuticals Daily ,Regeneron Pharmaceuticals Trading Down ,Securities Exchange Commission ,Householder Group Estate Retirement Specialist ,Exchange Commission ,Ritter Daniher Financial Advisory ,Free Report ,Financial Group ,Group Estate ,Retirement Specialist ,Capital Advisors ,Director Michael ,Director Arthur ,Pharmaceuticals Trading Down ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,